Simon Chan

Known for his practical problem solving skills for multinational clients, Simon acted as lead counsel for a range of transactions, including:

Select M&A and Private Equity Transactions:

• Represented iServe, a world leading e-commerce intelligence company headquartered in the US, in the acquisition of Practicology Ltd., a privately owned ecommerce consultancy company headquartered in London with presence in Hong Kong, China, Australia and Middle East. 
• Advised Scoular Company, a leading U.S.-based agricultural marketing company, in its acquisition of the Special Crops Division of Legumex Walker Inc. for transaction value of CAD$174.6 million.
• Advised Carlisle Companies Incorporated in the sale of Carlisle Transportation Products to private equity firm, American Industrial Partners for USD375 million.
• Advised Danish optics technology company, OPDI Technologies, on the joint venture transaction with Hong Kong publicly traded company, O-Net Communication. The deal is one of the recent largest Chinese outbound investments into a product/technology originated from Denmark.
• Acted as U.S. counsel to New World Development, a leading Hong Kong blue chip conglomerate, focusing on property, infrastructure and services, department stores and hotels in its tender offer to privatize its Hong Kong listed property flagship in the PRC for HKD22 billion (equivalent of around USD2.8 billion). 
• Advised Hong Kong based private equity firm, Joint Treasure International, in the global auction sale of their multi millions dollar real estate development project located in Beverly Hills, California, U.S.A. 
• Advised State Path Capital in its investments in Bionic Vision Technologies of Australia, among other investors including China Huarong International Holdings. 
• Advised Imation in the acquisitions of Japan’s TDK recording business and Memorex from Hong Kong sellers. 
• Advised Energizer in the USD930 million global acquisition of Schick and Wilkinson Sword razor lines from Pfizer. 

Select International Capital Markets transactions:

• Advised numerous US, UK and Canadian issuers and funds on their fund raising needs from Hong Kong and Asian investors.  
• Advised Powerlong Real Estate Holdings Limited, a leading property developer in the PRC, as to United States, Hong Kong and English law in connection with its various issuance of high yield bonds in 2017 and 2018. 
• Advising Hong Kong Stock Exchange listed issuers on International Economic Sanction law regime and related compliance issues pursuant to HKEX listing rules and guidance letters. 
• Acted as U.S. counsel to Genscript Biotech Corporation in its initial public offering in Hong Kong and concurrent Regulation S international offering outside the U.S. The sponsor was Haitong and the co-underwriters were Haitong and JP Morgan. Dorsey also acted as International Sanction Law counsel to Genscript covering sanction law issues involving Hong Kong, U.S., EU and United Nations, in compliance with HKEX LD76 of 2013 and relevant requirements.
• Advised Fulum Group, a leading Hong Kong based Chinese restaurant chain, as special U.S. and prospectus drafting counsel in its Hong Kong IPO and concurrent Reg S offering. 
• Advised Tsui Wah Holdings Limited, the leading Cha Chaan Teng chain owner and operator in Hong Kong, as special U.S. and prospectus drafting counsel in its Hong Kong IPO and concurrent Rule 144A / Reg S offering (USD97 million). 
• Advised Xiao Nan Guo Restaurants Holdings Limited, the largest self-owned mid-to high-end Chinese cuisine full-service restaurant chain headquartered in the PRC, as special U.S. counsel in its Hong Kong IPO and concurrent Rule 144A / Reg S offering (USD65 million). 
• Acted as US counsel to BNP Paribas, the sole sponsor and global coordinator for the IPO of Huiyin Household Appliances where the deal was named “Deal of the Year” by The Asset magazine. 
• Advised Hopewell Hong Kong Properties Limited, one of the leading developers, owners and operators of high quality properties in Hong Kong, as special U.S. counsel in its proposed spin-off from Hopewell Holdings Limited, a listed company in Hong Kong, via an initial public offering in Hong Kong and concurrent Rule 144A/ Reg S offering. The proposed deal was co-led by BOC International and Credit Suisse, with JP Morgan, HSBC and CITI as co-underwriters (offering postponed due to adverse market conditions).